Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
58.45
-1.50 (-2.50%)
At close: Apr 28, 2026, 4:00 PM EDT
58.48
+0.03 (0.05%)
After-hours: Apr 28, 2026, 7:59 PM EDT

Boston Scientific Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
20,61520,07416,74714,24012,68211,888
Revenue Growth (YoY)
17.44%19.87%17.61%12.29%6.68%19.92%
Cost of Revenue
6,3586,2215,2574,3453,9563,711
Gross Profit
14,25913,85411,4909,8968,7278,177
Selling, General & Admin
7,0726,8875,9845,1904,5204,359
Depreciation & Amortization Expenses
910897856828803741
Research & Development
2,1252,0521,6151,4141,3231,204
Other Operating Expenses
361405430120433675
Total Operating Expenses
10,46810,2418,8857,5527,0796,979
Operating Income
3,7933,6132,6032,3431,6491,199
Interest Expense
-357-349-305-265-470-341
Other Non-Operating Income (Expense)
306121-16-93-38218
Total Non-Operating Income (Expense)
-51-228-321-358-508-123
Pretax Income
3,7423,3852,2821,9851,1411,076
Provision for Income Taxes
18349343639344336
Net Income
3,5652,8981,8531,570642985
Minority Interest in Earnings
-6-6-8-1--
Net Income Attributable to Preferred Dividends
---235555
Net Income to Common
3,5652,8981,8531,570642985
Net Income Growth
75.44%56.39%18.02%144.55%-34.82%-
Shares Outstanding (Basic)
1,4821,4801,4721,4531,4311,431
Shares Outstanding (Diluted)
1,4951,4951,4861,4641,4401,442
Shares Change (YoY)
0.42%0.58%1.53%1.65%-0.16%1.79%
EPS (Basic)
2.401.961.261.080.450.72
EPS (Diluted)
2.391.941.251.070.450.72
EPS Growth
74.45%55.20%16.82%137.78%-37.50%-
Shares Outstanding
1,4841,4831,4751,4651,4331,425
Free Cash Flow
-3,6582,6451,7929381,316
Free Cash Flow Growth
-38.30%47.60%91.05%-28.72%16.25%
Free Cash Flow Per Share
-2.451.781.220.650.91
Gross Margin
69.17%69.01%68.61%69.49%68.81%68.78%
Operating Margin
18.40%18.00%15.54%16.45%13.00%10.09%
Profit Margin
17.26%14.41%11.02%11.18%5.50%8.75%
FCF Margin
-18.22%15.79%12.58%7.40%11.07%
EBITDA
3,7934,9813,8723,5392,7852,292
EBITDA Margin
18.40%24.81%23.12%24.85%21.96%19.28%
EBIT
3,7933,6132,6032,3431,6491,199
EBIT Margin
18.40%18.00%15.54%16.45%13.00%10.09%
Effective Tax Rate
4.89%14.56%19.11%19.80%38.83%3.35%
Updated Apr 22, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q